{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T12:01:03Z","timestamp":1776686463502,"version":"3.51.2"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.abd.2026.501299","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T07:35:57Z","timestamp":1773041757000},"page":"501299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of immunohistochemical and gene expression of Janus kinase 1 and Janus kinase 3 in the skin of different clinical types of mycosis fungoides patients \u2013 Part I"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9990-6862","authenticated-orcid":false,"given":"Heba Saed","family":"El-Amawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basma Mourad","family":"Mohamed Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Moustafa","family":"Shareef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamia","family":"Elgarhy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2026.501299_bib0005","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood."},{"key":"10.1016\/j.abd.2026.501299_bib0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.12788\/j.sder.2018.002","article-title":"Mycosis fungoides \u2012 clinical and histopathologic features differential diagnosis and treatment","volume":"37","author":"Cerroni","year":"2018","journal-title":"Semin Cutan Med Surg."},{"key":"10.1016\/j.abd.2026.501299_bib0015","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood."},{"key":"10.1016\/j.abd.2026.501299_bib0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00403-024-03533-9","article-title":"Dermoscopy of mycosis fungoides: could it be a confirmatory aid to the clinical diagnosis?","volume":"317","author":"Ali","year":"2024","journal-title":"Arch Dermatol Res."},{"key":"10.1016\/j.abd.2026.501299_bib0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.33545\/26649411.2023.v6.i1b.143","article-title":"Mycosis fungoides: review and updates","volume":"6","author":"El Amawy","year":"2023","journal-title":"Int J Dermatol Venereology Leprosy Sci."},{"key":"10.1016\/j.abd.2026.501299_bib0030","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/rheumatology\/key339","article-title":"Clinical significance of Janus Kinase inhibitor selectivity","volume":"58","author":"Choy","year":"2019","journal-title":"Rheumatology."},{"key":"10.1016\/j.abd.2026.501299_bib0035","doi-asserted-by":"crossref","first-page":"i43","DOI":"10.1093\/rheumatology\/key276","article-title":"New players in the field of immune-mediated diseases, beyond rheumatoid arthritis","volume":"58","author":"Fragoulis","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.abd.2026.501299_bib0040","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","article-title":"JAK inhibitors in dermatology: the promise of a new drug class","volume":"76","author":"Damsky","year":"2017","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2026.501299_bib0045","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-immunol-110416-120628","article-title":"Disorders of the JAK\/STAT pathway in T cell lymphoma pathogenesis: implications for immunotherapy","volume":"35","author":"Waldmann","year":"2017","journal-title":"Annu Rev Immunol."},{"key":"10.1016\/j.abd.2026.501299_bib0050","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood."},{"key":"10.1016\/j.abd.2026.501299_bib0055","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/bjd.12403","article-title":"How big is your hand and should you use it to score skin in cutaneous T\u2010cell lymphoma?","volume":"169","author":"Scarisbrick","year":"2013","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2026.501299_bib0060","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1034\/j.1600-0560.2001.028004174.x","article-title":"Histologic criteria for the diagnosis of mycosis fungoides: proposal for a grading system to standardize pathology reporting","volume":"28","author":"Guitart","year":"2001","journal-title":"J Cutan Pathol."},{"key":"10.1016\/j.abd.2026.501299_bib0065","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4132\/jptm.2018.09.18","article-title":"Immunohistochemistry of Janus kinase 1 (JAK1) expression in vitiligo","volume":"52","author":"Abdou","year":"2018","journal-title":"J Pathol Transl Med."},{"key":"10.1016\/j.abd.2026.501299_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13000-014-0221-9","article-title":"Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue\u2013a review","volume":"9","author":"Fedchenko","year":"2014","journal-title":"Diagn Pathol."},{"key":"10.1016\/j.abd.2026.501299_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/cco.2018.10.02","article-title":"The histological prevalence and clinical implications of folliculotropism and syringotropism in mycosis fungoides","volume":"8","author":"Hossain","year":"2019","journal-title":"Chin Clin Oncol."},{"key":"10.1016\/j.abd.2026.501299_bib0080","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ad.2020.12.003","article-title":"Janus kinase inhibitors in dermatology: Part 1 \u2012 general considerations and applications in vitiligo and alopecia areata","volume":"112","author":"Garcia-Melendo","year":"2021","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"10.1016\/j.abd.2026.501299_bib0085","first-page":"16","article-title":"Deregulated signalling and inflammation in cutaneous T\u2010cell lymphoma","volume":"182","author":"\u00d8dum","year":"2020","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2026.501299_bib0090","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.4161\/15384101.2014.965061","article-title":"Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression","volume":"13","author":"Netchiporouk","year":"2014","journal-title":"Cell Cycle."},{"key":"10.1016\/j.abd.2026.501299_bib0095","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1182\/blood.2019004725","article-title":"Genome-wide transcriptome analysis of the STAT6-regulated genes in advanced-stage cutaneous T-cell lymphoma","volume":"136","author":"Gaydosik","year":"2020","journal-title":"Blood."},{"key":"10.1016\/j.abd.2026.501299_bib0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/08977194.2011.614949","article-title":"JAKs go nuclear: emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth","volume":"29","author":"Zouein","year":"2011","journal-title":"Growth Factors."},{"key":"10.1016\/j.abd.2026.501299_bib0105","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/leu.2011.198","article-title":"Constitutive activation of STAT3 in S\u00e9zary syndrome is independent of SHP-1","volume":"26","author":"McKenzie","year":"2012","journal-title":"Leukemia."},{"key":"10.1016\/j.abd.2026.501299_bib0110","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.leu.2402093","article-title":"Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells","volume":"15","author":"Eriksen","year":"2001","journal-title":"Leukemia."},{"key":"10.1016\/j.abd.2026.501299_bib0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2147\/CCID.S210106","article-title":"Role of janus kinase 1 and signal transducer and activator of transcription 3 in vitiligo","volume":"12","author":"Samaka","year":"2019","journal-title":"Clin Cosmet Investig Dermatol."},{"key":"10.1016\/j.abd.2026.501299_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0164080","article-title":"JAK3 as an emerging target for topical treatment of inflammatory skin diseases","volume":"11","author":"Alves de Medeiros","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.abd.2026.501299_bib0125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2147\/CCID.S202835","article-title":"Immunohistochemical study of janus kinase 1\/signal transducer and activator of transcription 3 in psoriasis vulgaris","volume":"12","author":"Farag","year":"2019","journal-title":"Clin Cosmet Investig Dermatol."},{"key":"10.1016\/j.abd.2026.501299_bib0130","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.4049\/jimmunol.1202859","article-title":"A restricted role for TYK2 catalytic activity in human cytokine responses revealed by novel TYK2-selective inhibitors","volume":"191","author":"Sohn","year":"2013","journal-title":"J Immunol."},{"key":"10.1016\/j.abd.2026.501299_bib0135","first-page":"159","article-title":"Association analyses of the JAK\/STAT signaling pathway with the progression and prognosis of colon cancer","volume":"17","author":"Tang","year":"2019","journal-title":"Oncol Lett."},{"key":"10.1016\/j.abd.2026.501299_bib0140","series-title":"Fitzpatrick\u2019s dermatology in general medicine","first-page":"385","article-title":"Overview of biology, development, and structure of skin","author":"Chu","year":"2008"},{"key":"10.1016\/j.abd.2026.501299_bib0145","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK-STAT pathway: impact on human disease and therapeutic intervention","volume":"66","author":"O\u2019Shea","year":"2015","journal-title":"Annu Rev Med."},{"key":"10.1016\/j.abd.2026.501299_bib0150","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/cancers13020280","article-title":"JAK3 is expressed in the nucleus of malignant T cells in cutaneous T cell lymphoma (CTCL)","volume":"13","author":"Vadivel","year":"2021","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.abd.2026.501299_bib0155","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ad.2016.08.009","article-title":"Clinicopathologic variants of mycosis fungoides","volume":"108","author":"Mu\u00f1oz-Gonz\u00e1lez","year":"2017","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.abd.2026.501299_bib0160","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/cup.13882","article-title":"Comparison between the histopathological and immunophenotypical features of hypopigmented and nonhypopigmented mycosis fungoides: a retrospective study","volume":"48","author":"Jayasinghe","year":"2021","journal-title":"J Cutan Pathol."},{"key":"10.1016\/j.abd.2026.501299_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cpr.12307","article-title":"The JAK\/STAT 3 signalling pathway regulated angiogenesis in an endothelial cell\/adipose\u2010derived stromal cell co\u2010culture, 3D gel model","volume":"50","author":"Xue","year":"2017","journal-title":"Cell Proliferation"},{"key":"10.1016\/j.abd.2026.501299_bib0170","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1242\/bio.017798","article-title":"Downregulation of leptin inhibits growth and induces apoptosis of lung cancer cells via the notch and JAK\/STAT3 signaling pathways","volume":"5","author":"Zheng","year":"2016","journal-title":"Biol Open."},{"key":"10.1016\/j.abd.2026.501299_bib0175","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2016-01-690701","article-title":"EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer\/T-cell lymphoma","volume":"128","author":"Yan","year":"2016","journal-title":"Blood."},{"key":"10.1016\/j.abd.2026.501299_bib0180","doi-asserted-by":"crossref","first-page":"17700","DOI":"10.18632\/oncotarget.10775","article-title":"Capsazepine inhibits JAK\/STAT3 signaling, tumor growth, and cell survival in prostate cancer","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.abd.2026.501299_bib0185","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1182\/blood-2008-06-164368","article-title":"Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models","volume":"113","author":"Cornejo","year":"2009","journal-title":"Blood."},{"key":"10.1016\/j.abd.2026.501299_bib0190","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2340\/00015555-3207","article-title":"Expression of CCR3 and CCR4 suggests a poor prognosis in mycosis fungoides and S\u00e9zary syndrome","volume":"99","author":"Shono","year":"2019","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.abd.2026.501299_bib0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00403-017-1792-6","article-title":"Expression of janus kinase 1 in vitiligo & psoriasis before and after narrow band UVB: A case\u2013control study","volume":"310","author":"Nada","year":"2018","journal-title":"Arch Dermatol Res."},{"key":"10.1016\/j.abd.2026.501299_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13040800","article-title":"Janus kinases in leukemia","volume":"13","author":"Raivola","year":"2021","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.abd.2026.501299_bib0205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-065X.2008.00754.x","article-title":"Janus kinases in immune cell signaling","volume":"228","author":"Ghoreschi","year":"2009","journal-title":"Immunol Rev."},{"key":"10.1016\/j.abd.2026.501299_bib0210","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/sj.leu.2404350","article-title":"Jak3-and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma","volume":"20","author":"Krejsgaard","year":"2006","journal-title":"Leukemia."},{"key":"10.1016\/j.abd.2026.501299_bib0215","doi-asserted-by":"crossref","first-page":"15235","DOI":"10.18632\/oncotarget.3837","article-title":"Malignant T cells express lymphotoxin \u03b1 and drive endothelial activation in cutaneous T cell lymphoma","volume":"6","author":"Lauenborg","year":"2015","journal-title":"Oncotarget."},{"key":"10.1016\/j.abd.2026.501299_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-017-0177-y","article-title":"The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells","volume":"15","author":"Seif","year":"2017","journal-title":"Cell Commun Signal."},{"key":"10.1016\/j.abd.2026.501299_bib0225","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.immuni.2008.03.002","article-title":"Cytokine signaling modules in inflammatory responses","volume":"28","author":"O\u2019Shea","year":"2008","journal-title":"Immunity."},{"key":"10.1016\/j.abd.2026.501299_bib0230","first-page":"1","article-title":"JAK\/STAT signaling pathway and inhibitors in inflammatory and neoplasmatic skin diseases","volume":"6","author":"Karagianni","year":"2019","journal-title":"Ann Hematol Oncol."},{"key":"10.1016\/j.abd.2026.501299_bib0235","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00281-016-0594-9","article-title":"Malignant inflammation in cutaneous T\u2010cell lymphoma \u2012 a hostile takeover","volume":"39","author":"Krejsgaard","year":"2017","journal-title":"Semin Immunopathol."},{"key":"10.1016\/j.abd.2026.501299_bib0240","first-page":"395","article-title":"STATs: an old story, yet mesmerizing","volume":"17","author":"Abroun","year":"2015","journal-title":"Cell J."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059626000127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059626000127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:17:06Z","timestamp":1776683826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059626000127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0365059626000127"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2026.501299","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of immunohistochemical and gene expression of Janus kinase 1 and Janus kinase 3 in the skin of different clinical types of mycosis fungoides patients \u2013 Part I","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2026.501299","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501299"}}